Citace podle APA (7th ed.)

Canonica, G., Blasi, F., Crimi, N., Paggiaro, P., Papi, A., Fanelli, F., . . . Furneri, G. (2020). PRS50 Defining Type 2 Asthma and Patients Eligible to Dupilumab in Italy: A Biomarker-Based Analysis. Value in health, 23, S726. https://doi.org/10.1016/j.jval.2020.08.1930

Citace podle Chicago (17th ed.)

Canonica, G.W, F. Blasi, N. Crimi, P. Paggiaro, A. Papi, F. Fanelli, A. Stassaldi, A. Serra, a G. Furneri. "PRS50 Defining Type 2 Asthma and Patients Eligible to Dupilumab in Italy: A Biomarker-Based Analysis." Value in Health 23 (2020): S726. https://doi.org/10.1016/j.jval.2020.08.1930.

Citace podle MLA (9th ed.)

Canonica, G.W, et al. "PRS50 Defining Type 2 Asthma and Patients Eligible to Dupilumab in Italy: A Biomarker-Based Analysis." Value in Health, vol. 23, 2020, p. S726, https://doi.org/10.1016/j.jval.2020.08.1930.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..